Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension
Open Access
- 19 November 2010
- journal article
- systemic sclerosis
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (3), 783-794
- https://doi.org/10.1002/art.30159
Abstract
Objective Pulmonary complications, including pulmonary fibrosis (PF) and pulmonary arterial hypertension (PAH), are the leading cause of mortality in patients with systemic sclerosis (SSc). The aim of this study was to compare the molecular fingerprint of lung tissue and matching primary fibroblasts from patients with SSc with that of lung tissue and fibroblasts from normal donors, patients with idiopathic pulmonary fibrosis (IPF), and patients with idiopathic pulmonary arterial hypertension (IPAH). Methods Lung tissue samples were obtained from 33 patients with SSc who underwent lung transplantation. Tissues and cells from a subgroup of SSc patients with predominantly PF or PAH were compared to those from normal donors, patients with IPF, and patients with IPAH. Microarray data were analyzed using efficiency analysis for determination of the optimal data‐processing methods. Real‐time polymerase chain reaction and immunohistochemistry were used to confirm differential levels of messenger RNA and protein, respectively. Results Consensus efficiency analysis identified 242 and 335 genes that were differentially expressed in lungs and primary fibroblasts, respectively. SSc‐PF and IPF lungs shared enriched functional groups in genes implicated in fibrosis, insulin‐like growth factor signaling, and caveolin‐mediated endocytosis. Gene functional groups shared by SSc‐PAH and IPAH lungs included those involved in antigen presentation, chemokine activity, and interleukin‐17 signaling. Conclusion Using microarray analysis on carefully phenotyped SSc and comparator lung tissues, we demonstrated distinct molecular profiles in tissues and fibroblasts from patients with SSc‐associated lung disease compared to idiopathic forms of lung disease. Unique molecular signatures were generated that are disease specific (SSc) and phenotype specific (PF versus PAH). These signatures provide new insights into the pathogenesis and potential therapeutic targets of SSc‐related lung disease.Keywords
This publication has 41 references indexed in Scilit:
- Therapy for pulmonary arterial hypertension associated with systemic sclerosisCurrent Opinion in Rheumatology, 2009
- Anti–U11/U12 RNP antibodies in systemic sclerosis: A new serologic marker associated with pulmonary fibrosisArthritis Care & Research, 2009
- Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-β–like signaling pathwayJCI Insight, 2009
- Nitric Oxide–Mediated Zinc Release Contributes to Hypoxic Regulation of Pulmonary Vascular ToneCirculation Research, 2008
- Identification of candidate genes in scleroderma-related pulmonary arterial hypertensionTranslational Research, 2008
- Deficiency in the LIM-only protein Fhl2 impairs skin wound healingThe Journal of cell biology, 2007
- Changes in causes of death in systemic sclerosis, 1972-2002Annals Of The Rheumatic Diseases, 2007
- Gene Expression Profiling of Familial and Sporadic Interstitial PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosisThe Journal of Experimental Medicine, 2006
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001